-
Je něco špatně v tomto záznamu ?
Predictors of postoperative complications and functional outcomes in pediatric patients with surgically treated fourth ventricle tumors
K. Haratek, A. Bubeníková, CJ. Entenmann, M. Tomášek, M. Zápotocký, D. Sumerauer, M. Kynčl, M. Koblížek, P. Libý, M. Tichý, O. Bradáč, V. Beneš
Jazyk angličtina Země Rakousko
Typ dokumentu časopisecké články
Grantová podpora
NU23-08-00460
Ministerstvo Zdravotnictví Ceské Republiky
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- čtvrtá mozková komora diagnostické zobrazování chirurgie MeSH
- dítě MeSH
- lidé MeSH
- lokální recidiva nádoru chirurgie MeSH
- meduloblastom * chirurgie MeSH
- nádory mozečku * chirurgie etiologie MeSH
- neurochirurgické výkony škodlivé účinky MeSH
- pooperační komplikace epidemiologie etiologie chirurgie MeSH
- retrospektivní studie MeSH
- senioři MeSH
- výsledek terapie MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Tumors of the fourth ventricle are frequently treated pathologies in pediatric neurosurgery. Data regarding predictors for permanent neurological deficits, long-term functional outcomes, cerebellar mutism (CM), the extent of resection (EOR), and oncological outcomes are scarce. We attempt to contribute to this topic with an analysis of our institutional cohort. METHODS: A retrospective single-center study of patients aged ≤ 19 years who underwent primary surgical resection of a fourth ventricular tumor over a 15-year period (2006-2021). Predictors analyzed included age, gender, surgical approach, anatomical pattern, tumor grade, EOR, tumor volume, and others as appropriate. RESULTS: One hundred six patients were included (64 males, mean age 7.3 years). The rate of permanent neurological deficit was 24.2%; lateral tumor extension (p = 0.036) and tumor volume greater than 38 cm3 (p = 0.020) were significant predictors. The presence of a deficit was the only significant predictor of reduced (less than 90) Lansky score (p = 0.005). CM occurred in 20.8% of patients and was influenced by medulloblastoma histology (p = 0.011), lateral tumor extension (p = 0.017), and male gender (p = 0.021). No significant difference between the transvermian and telovelar approach in the development of CM was detected (p = 0.478). No significant predictor was found for the EOR. EOR was not found to be a significant predictor of overall survival for both low-grade and high-grade tumors; however, gross total resection (GTR) was protective against tumor recurrence compared to near-total or subtotal resection (p < 0.001). In addition, survival was found to be better in older patients (≥ 7.0 years, p = 0.019). CONCLUSION: The overall rate of postoperative complications remains high due to the eloquent localization. Older patients (> 7 years) have been found to have better outcomes and prognosis. Achieving GTR whenever feasible and safe has been shown to be critical for tumor recurrence. CM was more common in patients with medulloblastoma and in patients with tumors extending through the foramen of Luschka. The telovelar approach uses a safe and anatomically sparing corridor; however, it has not been associated with a lower incidence of CM and neurological sequelae in our series, showing that each case should be assessed on an individual basis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000527
- 003
- CZ-PrNML
- 005
- 20240213093231.0
- 007
- ta
- 008
- 240109s2023 au f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00701-023-05729-w $2 doi
- 035 __
- $a (PubMed)37535206
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a au
- 100 1_
- $a Haratek, Kryštof $u Department of Neurosurgery, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0009000362287967
- 245 10
- $a Predictors of postoperative complications and functional outcomes in pediatric patients with surgically treated fourth ventricle tumors / $c K. Haratek, A. Bubeníková, CJ. Entenmann, M. Tomášek, M. Zápotocký, D. Sumerauer, M. Kynčl, M. Koblížek, P. Libý, M. Tichý, O. Bradáč, V. Beneš
- 520 9_
- $a BACKGROUND: Tumors of the fourth ventricle are frequently treated pathologies in pediatric neurosurgery. Data regarding predictors for permanent neurological deficits, long-term functional outcomes, cerebellar mutism (CM), the extent of resection (EOR), and oncological outcomes are scarce. We attempt to contribute to this topic with an analysis of our institutional cohort. METHODS: A retrospective single-center study of patients aged ≤ 19 years who underwent primary surgical resection of a fourth ventricular tumor over a 15-year period (2006-2021). Predictors analyzed included age, gender, surgical approach, anatomical pattern, tumor grade, EOR, tumor volume, and others as appropriate. RESULTS: One hundred six patients were included (64 males, mean age 7.3 years). The rate of permanent neurological deficit was 24.2%; lateral tumor extension (p = 0.036) and tumor volume greater than 38 cm3 (p = 0.020) were significant predictors. The presence of a deficit was the only significant predictor of reduced (less than 90) Lansky score (p = 0.005). CM occurred in 20.8% of patients and was influenced by medulloblastoma histology (p = 0.011), lateral tumor extension (p = 0.017), and male gender (p = 0.021). No significant difference between the transvermian and telovelar approach in the development of CM was detected (p = 0.478). No significant predictor was found for the EOR. EOR was not found to be a significant predictor of overall survival for both low-grade and high-grade tumors; however, gross total resection (GTR) was protective against tumor recurrence compared to near-total or subtotal resection (p < 0.001). In addition, survival was found to be better in older patients (≥ 7.0 years, p = 0.019). CONCLUSION: The overall rate of postoperative complications remains high due to the eloquent localization. Older patients (> 7 years) have been found to have better outcomes and prognosis. Achieving GTR whenever feasible and safe has been shown to be critical for tumor recurrence. CM was more common in patients with medulloblastoma and in patients with tumors extending through the foramen of Luschka. The telovelar approach uses a safe and anatomically sparing corridor; however, it has not been associated with a lower incidence of CM and neurological sequelae in our series, showing that each case should be assessed on an individual basis.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a čtvrtá mozková komora $x diagnostické zobrazování $x chirurgie $7 D020546
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a neurochirurgické výkony $x škodlivé účinky $7 D019635
- 650 12
- $a meduloblastom $x chirurgie $7 D008527
- 650 _2
- $a lokální recidiva nádoru $x chirurgie $7 D009364
- 650 _2
- $a pooperační komplikace $x epidemiologie $x etiologie $x chirurgie $7 D011183
- 650 12
- $a nádory mozečku $x chirurgie $x etiologie $7 D002528
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bubeníková, Adéla $u Department of Neurosurgery, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000245329219
- 700 1_
- $a Entenmann, Christian Joachim $u Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Berlin, Germany $1 https://orcid.org/0000000264026766
- 700 1_
- $a Tomášek, Martin $u Department of Neurosurgery, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $u Center for Pediatric Neuro-Oncology, University Hospital Motol, V Úvalu 84, 150 06, Prague 5, Prague, Czech Republic
- 700 1_
- $a Zápotocký, Michal $u Center for Pediatric Neuro-Oncology, University Hospital Motol, V Úvalu 84, 150 06, Prague 5, Prague, Czech Republic $u Department of Pediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000290132546 $7 xx0099530
- 700 1_
- $a Sumerauer, David $u Center for Pediatric Neuro-Oncology, University Hospital Motol, V Úvalu 84, 150 06, Prague 5, Prague, Czech Republic $u Department of Pediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Kynčl, Martin $u Center for Pediatric Neuro-Oncology, University Hospital Motol, V Úvalu 84, 150 06, Prague 5, Prague, Czech Republic $u Department of Radiology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Koblížek, Miroslav $u Center for Pediatric Neuro-Oncology, University Hospital Motol, V Úvalu 84, 150 06, Prague 5, Prague, Czech Republic $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/000000028422732X
- 700 1_
- $a Libý, Petr $u Department of Neurosurgery, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $u Center for Pediatric Neuro-Oncology, University Hospital Motol, V Úvalu 84, 150 06, Prague 5, Prague, Czech Republic $1 https://orcid.org/000000018392795X
- 700 1_
- $a Tichý, Michal $u Department of Neurosurgery, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $u Center for Pediatric Neuro-Oncology, University Hospital Motol, V Úvalu 84, 150 06, Prague 5, Prague, Czech Republic
- 700 1_
- $a Bradáč, Ondřej $u Department of Neurosurgery, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic $u Center for Pediatric Neuro-Oncology, University Hospital Motol, V Úvalu 84, 150 06, Prague 5, Prague, Czech Republic $1 https://orcid.org/0000000343645522 $7 xx0121581
- 700 1_
- $a Beneš, Vladimír $u Department of Neurosurgery, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic. vladimir.benes@fnmotol.cz $u Center for Pediatric Neuro-Oncology, University Hospital Motol, V Úvalu 84, 150 06, Prague 5, Prague, Czech Republic. vladimir.benes@fnmotol.cz $1 https://orcid.org/0000000272690392
- 773 0_
- $w MED00009022 $t Acta neurochirurgica $x 0942-0940 $g Roč. 165, č. 12 (2023), s. 4279-4292
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37535206 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093228 $b ABA008
- 999 __
- $a ok $b bmc $g 2049278 $s 1210221
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 165 $c 12 $d 4279-4292 $e 20230803 $i 0942-0940 $m Acta neurochirurgica $n Acta Neurochir $x MED00009022
- GRA __
- $a NU23-08-00460 $p Ministerstvo Zdravotnictví Ceské Republiky
- LZP __
- $a Pubmed-20240109